Adrenal cortex autoantibodies in subjects with normal adrenal function

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 19, Issue 1, 2005, Pages 85-99

  Betterle, Corrado ^a   Coco, Graziella ^a   Zanchetta, Renato ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

21 hydroxylase autoantibodies; Addison's disease; Adrenal cortex autoantibodies; Autoimmune diseases; Pre Addison's disease

Indexed keywords

ALDOSTERONE; AUTOANTIBODY; CORTICOSTEROID; CORTICOTROPIN; HYDROCORTISONE; STEROID 21 MONOOXYGENASE;

ADDISON DISEASE; ANTIBODY SCREENING; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; DISEASE COURSE; DISEASE SEVERITY; ENDOCRINE FUNCTION TEST; HIGH RISK POPULATION; HUMAN; HYPOPARATHYROIDISM; IMMUNOFLUORESCENCE; OVARY INSUFFICIENCY; PLASMA RENIN ACTIVITY; RADIOIMMUNOASSAY; RISK ASSESSMENT;

EID: 13844253757     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2004.11.008     Document Type: Review

References (72)

1. Chapel H, Haeney M, Misbach S & Snowden N. Autoimmunity. In: Essentials of Clinical Immunology. Oxford: Blackwell Science; 1999 pp. 95-110.
2. A. Davidson B. Diamond Autoimmune diseases N Engl J Med 345 2004 340-350
3. R.H. Slover G.S. Eisenbarth Prevention of type I diabetes and recurrent beta-cell destruction of transplanted islets Endocr Rev 18 1997 241-258
4. M.P. Vanderpump W.M. Tunbridge J.M. French et al. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey Clin Endocrinol (Oxf) 43 1995 55-68
5. C. Betterle C. Dal Pra F. Mantero R. Zanchetta Autoimmune adrenal insuffciency and autoimmune polyendocrine syndromes: Autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction Endocr Rev 23 2002 327-364
6. A. Hoek J. Schoemaker H.A. Drehhage Premature ovarian failure and ovarian autoimmunity Endocr Rev 18 1997 107-134
7. C. Catassi I.-M. Ratsch E. Fabiani et al. Coeliac disease in the year 2000: Exploring the iceberg Lancet 343 1994 200-203
8. D. Agardh A. Nilsson T. Tuomi et al. Prediction of silent celiac disease at diagnosis of childhood type 1 diabetes by tissue transglutaminase autoantibodies and HLA Pediatr Diab 2 2001 58-65
9. K.E. Kisand K. Metskula K.V. Kisand et al. The follow-up of asymptomatic persons with antibodies to pyruvate dehydrogenase in adult population samples J Gastroenterol 36 2001 248-254
10. R.H. Scofield Autoantibodies as predictor of disease Lancet 363 2004 1544-1546
11. M.R. Arbuckle M.T. McClair M.V. Rubertone et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus N Engl J Med 349 2003 1526-1533
12. M.M. Nielen D. Schaardenburg H.W. Reesink et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors Arthritis Rheum 50 2004 380-386
13. T. Berger P. Rubner F. Schautzer et al. Antimyelin antibodies as a predictor of clinically definite sclerosis after first demyelinating event N Engl J Med 349 2004 139-145
14. J.R. Anderson R.B. Goudie K.G. Gray G.C. Timbury Autoantibodies in Addison's disease Lancet 1 1957 1123-1124
15. Betterle C. Addison's disease and polyglandular syndromes. In: Geenen V & Chrosus G (Eds.) Immunoendocrinology in Health Disease. New York: Marcel Dekker Inc. 2004.
16. R.M. Blizzard M. Kyle Studies of the adrenal antigens and autoantibodies in Addison's disease J Clin Invest 42 1963 1653-1660
17. E.L. Khoury L. Hammond G.F. Bottazzo D. Doniach Surface-reactive antibodies to human adrenal cells in Addison's disease Clin Exp Immunol 45 1981 48-55
18. O. Winqvist F.A. Karlsson O. Kämpe 21-hydroxylase, a major autoantigen in idiopathic Addison's disease Lancet 339 1992 1559-1562
19. A. Baumann-Antczak N. Wedlock J. Bednarek et al. Autoimmune Addison's disease and 21-hydroxylase Lancet 340 1992 429-430
20. J. Colls C. Betterle M. Volpato et al. A new immunoprecipitation assay for autoantibodies to steroid 21-hydroxylase in Addison's disease Clin Chem 41 1995 375-380
21. H. Tanaka M. Powell S. Chen et al. Autoimmune adrenal diseases- a new sensitive assay for measurement of steroid 21-hydroxylase autoantibodies J Clin Endocrinol Metab 82 1997 1440-1446
22. C. Betterle M. Volpato B. Pedini et al. Adrenal-cortex autoantibodies (ACA) and steroid-producing cells autoantibodies (StCA) in patients with Addison's disease: Comparison between immunofluorescence and immunoprecipitation assays J Clin Endocrinol Metab 84 1999 618-622
23. P. Kendall-Taylor A. Lambert R. Mitchell W.R. Robertson Antibody that blocks stimulation of cortisol secretion by adrenocorticotrophic hormone in Addison's disease Br Med J 296 1988 1489-1491
24. N.M. Wulffraat H.A. Drexhage G.F. Bottazzo et al. Immunoglobulins of patients with Addison's disease block the in vitro action of adrenocorticotropin J Clin Endocrinol Metab 69 1989 231-238
25. C.A. Wardle A.P. Weetman R. Mitchell et al. Adrenocorticotropic hormone receptor-blocking immunoglobulins in serum from patients with Addison's disease: A reexamination J Clin Endocrinol Metab 77 1993 750-753
26. J.U. Anderson R.B. Goudie K. Gray D.A. Stuart Smith Immunological features of idiopathic Addison's disease: An antibody to cells producing steroid hormones Clin Exp Immunol 3 1968 107-117
27. F. Sotsiou G.F. Bottazzo D. Doniach Immunofluorescence studies on autoantibodies to steroid-producing cells, and to germline cells in endocrine disease and infertility Clin Exp Immunol 39 1980 97-111
28. K. Krohn R. Uibo E. Aavik et al. Identification by molecolar cloning of an autoantigen associated with Addison's disease as steroid 17a-hydroxylase Lancet 339 1992 770-773
29. R. Uibo E. Aavik P. Peterson et al. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17 and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease J Clin Endocrinol Metab 78 1994 323-328
30. C. Dal Pra S. Chen J. Furmaniak et al. Autoantibodies to steroidogenic enzymes in patients with premature ovarian failure with and without Addison's disease Eur J Endocrinol 148 2003 565-570
31. R.H. Shmerling Autoantibodies in systemic lupus erythematosus - There before you know it N Engl J Med 349 2003 1499-1500
32. J. Furmaniak S. Kominami T. Asawa et al. Autoimmune Addison's disease. Evidence for a role of steroid 21-hydroxylase autoantibodies in adrenal insufficiency J Clin Endocrinol Metab 79 1994 1517-1521
33. M. Boscaro C. Betterle M. Volpato et al. Hormonal responses during various phases of autoimmune adrenal failure: No evidence for 21-hydroxylase enzyme activity in vivo J Clin Endocrinol Metab 81 1996 2801-2804
34. Betterle C, Dal Pra C, Pedini B, et al. Assessment of adrenocortical function and autoantibodies in a baby born to a mother with autoimmune polyglandular syndrome Type 2. J Endocrinol Invest 2004; 27: 618-621.
35. K.P. McNatty R.V. Short The cytotoxic effect of the serum from patients with Addison's disease and autoimmune ovarian failure on human granulosa cells in culture Clin Exp Immunol 22 1975 378-384
36. R.M. Blizzard D. Chee W. Davis The incidence of parathyroid and other antibodies in the sera of patients with idiopatic hypoparathyroidism Clin Exp Immunol 1 1966 119-128
37. W.J. Irvine A.G. Stewart L. Scarth A clinical and immunological study of adrenocortical insufficiency (Addison's disease) Clin Exp Immunol 2 1967 31-69
38. M.W. Spinner R.M. Blizzard J. Gibbs et al. Familial distributions of organ specific antibodies in the blood of patients with Addison's disease and hypoparathyroidism and their relatives Clin Exp Immunol 5 1969 461-468
39. K.D. Wuepper L.C. Weigienka H. Hugh Fudenberg Immunologic aspect of adrenocortical insufficiency Am J Med 46 1969 206-216
40. G. Pousset J.C. Monier J. Thivolet Anticorps antisurrènaliens et maladie d'Addison Ann Endocrinol 31 1970 995-1002
41. J. Nerup Addison's disease-serological studies Acta Endocrinologica 76 1974 142-158
42. W.J. Irvine E.W. Barnes Addison's disease, ovarian failure and hypoparathyroidism Clin Endocrinol Metab 4 1975 379-434
43. J.W. Riley N. Maclaren M. Neufeld Adrenal antibodies and Addison's disease in insulin-dependent diabetes mellitus J Pediatr 97 1980 191-195
44. M. Elder N. Maclaren W. Riley Gonadal autoantibodies in patients with hypogonadism and/or Addison disease J Clin Endocrinol Metab 52 1981 1137-1142
45. W.A. Scherbaum P.A. Berg Development of adrenocortical failure in non-addisonian patients with antibodies to adrenal cortex Clin Endocrinol 16 1982 345-352
46. R.J. Eason M.S. Croxon M.C. Perry S.D. Somerfield Addison's disease, adrenal autoantibodies and computerized adrenal tomography N Z Med J 95 1982 569-573
47. C. Betterle R. Zanchetta A. Trevisan et al. Complement-fixing adrenal autoantibodies as a marker for predicting onset of idiopathic Addison's disease Lancet 1 1983 1238-1240
48. C.H. Ketchum W.J. Riley N. MacLaren Adrenal dysfunction in asymptomatic patients with adrenocortical antibodies J Clin Endocrinol Metab 58 1984 1166-1170
49. C. Betterle C. Scalici F. Presotto et al. The natural history of adrenal function in autoimmune patients with adrenal autoantibodies J Endocrinol 117 1988 467-475
50. A. DeBellis A. Bizzarro R. Rossi et al. Remission of subclinical adrenocortical failure in subjects with adrenal autoantibodies J Clin Endocrinol Metab 76 1993 1002-1007
51. C. Betterle M. Volpato B. Rees Smith I. et al. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: Markers of low progression to clinical Addison's disease J Clin Endocrinol Metab 82 1997 932-938
52. C. Betterle M. Volpato B. Rees Smith et al. II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: Markers of high progression to clinical Addison's disease J Clin Endocrinol Metab 82 1997 939-942
53. A. Falorni S. Laureti A. Nikoshkov et al. 21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease Clin Exp Immunol 107 1997 341-346
54. P. Peterson H. Salmi H. Hyoty et al. Steroid 21-hydroxylase autoantibodies in insulin-dependent diabetes mellitus Clin Immunol Immunopathol 82 1997 37-42
55. V. Degros L. Pons A. Ghulam A. Racadot Intéret du dosage des anticorpo anti-21-hydroxylase comme marquer de l'atteinte surrénale dans les endocrinopathies auto-immunes Ann Biol Clin 57 1999 705-709
56. L. Yu K.W. Brewer S. Gates et al. DRB1*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease J Clin Endocrinol Metab 84 1999 328-335
57. R. do Carmo Silva C.E. Kater S. Atala Dib et al. Autoantibodies against recombinant human steroidogenic enzymes 21-hydroxylase, side chain cleavage and 17a-hydroxylase in Addison's disease and autoimmune polyendocrine syndrome type III Eur J Endocrinol 142 2000 187-194
58. C.E.M. De Block I.H. De Leeuw J.J.F. Vertommen et al. Beta-cell, thyroid, gastric, adrenal, and coeliac autoimmunity and HLA-DQ types in type 1 diabetes Clin Exp Immunol 126 2001 236-241
59. B. Wesche E. Jaeckel C. Trautwein et al. Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C Gut 48 2001 378-383
60. V.K. Bakalov V.H. Vanderhoof C.A. Bondy L.M. Nelson Adrenal antibodies detect asymptomatic auto-immuneadrenal insufficiency in young women with spontaneous premature ovarian failure Hum Reprod 17 2002 2096-2100
61. R.C. Silva C. Sallorenzo C.E. Kater et al. Autoantibodies against glutamic acid decarboxylase and 21-hydroxylase in Brazilian patients with type 1 diabetes or autoimmune thyroid diseases Diab Nutr Metab 16 2003 160-168
62. C. Betterle A. Rossi A. Artifoni et al. Premature ovarian failure: autoimmunity and natural history Clin Endocrinol 39 1993 35-43
63. J.R. Anderson Auto-antibodies in diseases of man Br Med Bull 19 1963 251-256
64. J.P. Simmonds J. Lister Autoimmune Addison's disease in identical twins Postgrad Med J 54 1978 552-554
65. P. Ahonen A. Miettinen J. Perheentupa Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure J Clin Endocrinol Metab 64 1987 494-500
66. S. Laureti A.M. De Bellis V.I. Muccitelli et al. Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects in subjects with preclinical Addison's disease J Clin Endocrinol Metab 83 1998 3507-3511
67. P. Fabris C. Betterle A. Floreani et al. Development of type 1 diabetes by interferon-alfa therapy for chronic HCV hepatitis Lancet 340 1992 548
68. P. Fabris A.R. Floreani G. Tositti et al. Type 1 diabetes mellitus in patients with HCV chronic hepatitis before and after interferon therapy Aliment Pharmacol Ther 18 2003 549-558
69. A. Floreani M. Chiaramente N.A. Greggio et al. Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients Ital J Gastroenterol Hepatol 30 1998 71-76
70. Y. Oppenheim Y. Ban Y. Tomer Interferon induced autoimmune thyroid disease (AITD): A model for human autoimmunity Autoimmun Rev 3 2004 388-393
71. S. Laureti E. Arva P. Candeloro et al. Low dose (1 μg) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease Clin Endocrinol 53 2000 107-115
72. A. De Bellis A. Falorni S. Laureti et al. Time course of 21-hydroxylase autoantibodies and long term remission of subclinical autoimmune adrenalitis after corticosteroid therapy: Case report J Clin Endocrinol Metab 86 2001 675-678